The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Recent Advances in Ophthalmic Drug Delivery
Open accessAbstract
Topical ocular drug bioavailability is notoriously poor, in the order of 5% or less. This is a consequence of effective multiple barriers to drug entry, comprising nasolacrimal drainage, epithelial drug transport barriers and clearance from the vasculature in the conjunctiva. While sustained drug delivery to the back of the eye is now feasible with intravitreal implants such as Vitrasert (-6 months), Retisert (-3 years) and Iluvien (-3 years), currently there are no marketed delivery systems for long-term drug delivery to the anterior segment of the eye. The purpose of this article is to summarize the resurgence in interest to prolong and improve drug entry from topical administration. These approaches include mucoadhesives, viscous polymer vehicles, transporter-targeted prodrug design, receptor-targeted functionalized nanoparticles, iontophoresis, punctal plug and contact lens delivery systems. A few of these delivery systems might be useful in treating diseases affecting the back of the eye. Their effectiveness will be compared against intravitreal implants (upper bound of effectiveness) and trans-scleral systems (lower bound of effectiveness). Refining the animal model by incorporating the latest advances in microdialysis and imaging technology is key to expanding the knowledge central to the design, testing and evaluation of the next generation of innovative ocular drug delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kadam, R. S., & Kompella, U. B. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.161570 · Cited by 47
Self-citationRetractedHydrophilic gels for biological use
WICHTERLE, O., & LÍM, D. (1960) · Nature · doi:10.1038/185117a0 · Cited by 2,996
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Permeability of cornea, sclera, and conjunctiva: A literature analysis for drug delivery to the eye
Prausnitz, M. R., & Noonan, J. S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802594 · Cited by 627
Age-related macular degeneration (AMD): pathogenesis and therapy.
Nowak, J. Z. (2006) · PubMed · Cited by 623
Intravitreal Injection of Triamcinolone for Diffuse Diabetic Macular Edema
Jonas, J. B. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.1.57 · Cited by 563
Topical Ocular Drug Delivery: Recent Developments and Future Challenges
LEE, V. H. L., & ROBINSON, J. R. (1986) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1986.2.67 · Cited by 503
Self-citationIntravitreal triamcinolone acetonide for exudative age related macular degeneration
Jonas, J. B. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.4.462 · Cited by 492
INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
DANIS, R. P., CIULLA, T. A., & PRATT, W. A. (2000) · Retina · doi:10.1097/00006982-200003000-00004 · Cited by 423
Netland, P. A., Landry, T., Sullivan, E. K., Andrew, R., Silver, L., Weiner, A., Mallick, S., Dickerson, J., Bergamini, M. V. W., Robertson, S. M., et al. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01177-1 · Cited by 417
Current and future ophthalmic drug delivery systems
del Amo, E. M., & Urtti, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.002 · Cited by 414
Felt, O. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00003-4 · Cited by 358
Rein, D. B. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.58 · Cited by 344
Cyclodextrins in ophthalmic drug delivery
Loftssona, T. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00055-6 · Cited by 305
Ophthalmic Drug Delivery through Contact Lenses
Gulsen, D., & Chauhan, A. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0959 · Cited by 304
Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle
Gulsen, D., & Chauhan, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.033 · Cited by 277
Periocular routes for retinal drug delivery
Raghava, S., Hammond, M., & Kompella, U. B. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.99 · Cited by 257
Self-citationImprinted soft contact lenses as norfloxacin delivery systems
Alvarez-Lorenzo, C., Yañez, F., Barreiro-Iglesias, R., & Concheiro, A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.003 · Cited by 252
Karlgard, C., Wong, N. S.-W., Jones, L., & Moresoli, C. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00124-8 · Cited by 250
Wei, G., Xu, H., Ding, P. T., Li, S. M., & Zheng, J. M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00175-x · Cited by 248
Ciolino, J. B., Hoare, T. R., Iwata, N. G., Behlau, I., Dohlman, C. H., Langer, R., & Kohane, D. S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2826 · Cited by 248
Safety evaluation of ocular drug delivery formulations: Techniques and practical considerations
Short, B. G. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310955 · Cited by 244
CHIN, H.-S., PARK, T.-S., MOON, Y.-S., & OH, J.-H. (2005) · Retina · doi:10.1097/00006982-200507000-00002 · Cited by 242
Kompella, U. B., Bandi, N., & Ayalasomayajula, S. P. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0791 · Cited by 239
Self-citationThe Effect of Topical Bevacizumab on Corneal Neovascularization
Kim, S. W., Ha, B. J., Kim, E. K., Tchah, H., & Kim, T.-I. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.02.013 · Cited by 239
Hiratani, H., & Alvarez-Lorenzo, C. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00213-4 · Cited by 235
Intraocular implants for extended drug delivery: Therapeutic applications
Bourges, J. L., Bloquel, C., Thomas, A., Froussart, F., Bochot, A., Azan, F., Gurny, R., BenEzra, D., & Behar-Cohen, F. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.026 · Cited by 235
Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses
Kim, J., Conway, A., & Chauhan, A. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.030 · Cited by 223
Secondary Chronic Open-Angle Glaucoma After Intravitreal Triamcinolone Acetonide
Jonas, J. B. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.5.729 · Cited by 218
Iontophoresis: A non-invasive ocular drug delivery
Eljarrat-Binstock, E., & Domb, A. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.049 · Cited by 216
Novel approaches to retinal drug delivery
Janoria, K. G., Gunda, S., Boddu, S. H., & Mitra, A. K. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.4.371 · Cited by 213
Mucosal penetration enhancers for facilitation of peptide and protein drug absorption.
Lee, V. H. L., Yamamoto, A., & Kompella, U. B. (1991) · PubMed · Cited by 213
Self-citationAli, M., Horikawa, S., Venkatesh, S., Saha, J., Hong, J. W., & Byrne, M. E. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.006 · Cited by 211
Calonge, M. (2001) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00205-8 · Cited by 186
Transport processes across the rabbit corneal epithelium: a review
Klyce, S. D., & Crosson, C. E. (1985) · Current Eye Research · doi:10.3109/02713688509025145 · Cited by 185
Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment
Olsen, T. W., Feng, X., Wabner, K., Conston, S. R., Sierra, D. H., Folden, D. V., Smith, M. E., & Cameron, J. D. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.05.045 · Cited by 171
Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome
Balaram, M., Schaumberg, D. A., & Dana, M. R. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00620-6 · Cited by 163
Amrite, A. C., Ayalasomayajula, S. P., Cheruvu, N. P. S., & Kompella, U. B. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0531 · Cited by 162
Self-citationIntravitreal Triamcinolone Acetonide: A Change in a Paradigm
Jonas, J. B. (2006) · Ophthalmic Research · doi:10.1159/000093796 · Cited by 160
Dispersion of DMPC Liposomes in Contact Lenses for Ophthalmic Drug Delivery
Gulsen, D., Li, C.-C., & Chauhan, A. (2005) · Current Eye Research · doi:10.1080/02713680500346633 · Cited by 159
Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs
Kapoor, Y., Thomas, J. C., Tan, G., John, V. T., & Chauhan, A. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.032 · Cited by 151
Choonara, Y. E., Pillay, V., Danckwerts, M. P., Carmichael, T. R., & du Toit, L. C. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21987 · Cited by 142
Wang, W., Sasaki, H., Chien, D., & Lee, V. H. L. (1991) · Current Eye Research · doi:10.3109/02713689109001766 · Cited by 142
Self-citationAyalasomayajula, S. P., & Kompella, U. B. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.019 · Cited by 141
Self-citationrhEGF/HP-β-CD complex in poloxamer gel for ophthalmic delivery
Kim, E. Y., Gao, Z.-G., Park, J., et al. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00933-4 · Cited by 129
Amrite, A. C., Edelhauser, H. F., Singh, S. R., & Kompella, U. B. (2008) · PubMed Central · Cited by 125
Self-citationHehl, E.-M., Beck, R., Luthard, K., et al. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050635 · Cited by 116
Subconjunctival Nanoparticle Carboplatin in the Treatment of Murine Retinoblastoma
Kang, S. J. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.185 · Cited by 113
Cheruvu, N. P. S., & Kompella, U. B. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0404 · Cited by 107
Self-citationInner Blood-Retinal Barrier Transporters: Role of Retinal Drug Delivery
Hosoya, K., & Tachikawa, M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9930-2 · Cited by 105
Active chloride transport in the pigmented rabbit conjunctiva
Kompella, U. B., Kim, K.-J., & Lee, V. H. L. (1993) · Current Eye Research · doi:10.3109/02713689309033501 · Cited by 100
Self-citationEffect of Eye Pigmentation on Transscleral Drug Delivery
Cheruvu, N. P. S., Amrite, A. C., & Kompella, U. B. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0214 · Cited by 95
Self-citationKristinsson, J. K., Friðriksdóttir, H., Thórisdóttir, S., et al. (1996) · PubMed · Cited by 94
Saishin, Y., Silva, R. L., Saishin, Y., Callahan, K. P., Schoch, C., Ahlheim, M., Lai, H. C., Kane, F. E., Brazzell, R. K., Bodmer, D., et al. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0600 · Cited by 94
Danion, A., Arsenault, I., & Vermette, P. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20871 · Cited by 93
Subconjunctival Carboplatin in Fibrin Sealant in the Treatment of Transgenic Murine Retinoblastoma
VANQUILL, K., Dioguardi, P. K., TONG, C., Gilbert, J. A., AABERGJR, T., Grossniklaus, H. E., EDELHAUSER, H., & OBRIEN, J. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.11.060 · Cited by 91
Durairaj, C., Shah, J. C., Senapati, S., & Kompella, U. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9728-7 · Cited by 91
Self-citationTolerance of Ocular Iontophoresis in Healthy Volunteers
Parkinson, T. M., Ferguson, E. H., Febbraro, S., Bakhtyari, A., King, M., & Mundasad, M. (2003) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076803321637672 · Cited by 91
Ophthalmic Drug Delivery: Development and Regulatory Considerations
Novack, G. D. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.297 · Cited by 87
Koushik, K., & Kompella, U. B. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019308.25479.a4 · Cited by 86
Self-citationOttiger, M., Thiel, M. A., Feige, U., Lichtlen, P., & Urech, D. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2372 · Cited by 85
Efflux Protein Expression in Human Retinal Pigment Epithelium Cell Lines
Mannermaa, E., Vellonen, K., Ryhänen, T., Kokkonen, K., Ranta, V., Kaarniranta, K., & Urtti, A. O. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9890-6 · Cited by 79
Modeling of Corneal and Retinal Pharmacokinetics after Periocular Drug Administration
Amrite, A. C., Edelhauser, H. F., & Kompella, U. B. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0593 · Cited by 78
Self-citationAcheampong, A., Shackleton, M., Tang-Liu, D. D.-S., Ding, S., Stern, M. E., & Decker, R. (1999) · Current Eye Research · doi:10.1076/ceyr.18.2.91.5381 · Cited by 78
Gehlbach, P. L., Demetriades, A. M., Yamamoto, S., Deering, T. G., Duh, E. J., Yang, H. S., Cingolani, C., Lai, H. C., Wei, L. L., & Campochiaro, P. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301931 · Cited by 77
INTRAVITREAL CONCENTRATION AND CLEARANCE OF TRIAMCINOLONE ACETONIDE IN NONVITRECTOMIZED HUMAN EYES
MASON, J. O., Somaiya, M. D., & Singh, R. (2004) · Retina · doi:10.1097/00006982-200412000-00009 · Cited by 77
Kompella, U. B., Sundaram, S., Raghava, S., & Escobar, E. R. (2006) · PubMed · Cited by 77
Self-citationAyalasomayajula, S. P., & Kompella, U. B. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045231.51924.e8 · Cited by 69
Self-citationEvaluation of a Delivery System Providing Long-term Release of Cyclosporine
Pearson, P. A. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100130307014 · Cited by 69
Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits
Loftsson, Þ., Friðriksdóttir, H., Stefánsson, E., Thórisdóttir, S., Gudmundsson, Ó. S., & Sigthórsson, T. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03835.x · Cited by 65
Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice.
Kim, T., Lindsey, J. D., Aihara, M., Anthony, T. L., & Weinreb, R. N. (2002) · PubMed · Cited by 57
Ocular Pharmacokinetics in Rabbits using a Novel Dual Probe Microdialysis Technique
Macha, S., & Mitra, A. K. (2001) · Experimental Eye Research · doi:10.1006/exer.2000.0953 · Cited by 57
Ciprofloxacin Interaction with Silicon-Based and Conventional Hydrogel Contact Lenses
Karlgard, C., Jones, L., & Moresoli, C. (2003) · Eye & Contact Lens Science & Clinical Practice · doi:10.1097/01.icl.0000061756.66151.1c · Cited by 57
[Possibility of the application of ophthalmic drugs with the use of gel contact lenses].
Sedlácek, J. (1965) · PubMed · Cited by 51
Hellberg, M. R., Ke, T.-L., Haggard, K. S., Klimko, P. G., Dean, T. R., & Graff, G. (2003) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076803321637627 · Cited by 50
Bary, A. R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00108-9 · Cited by 49
Hornof, M., & Bernkop‐Schnürch, A. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10258 · Cited by 46
Sustained Subconjunctival Protein Delivery Using a Thermosetting Gel Delivery System
Rieke, E. R., Amaral, J., Becerra, S. P., & Lutz, R. J. (2010) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2009.0059 · Cited by 45
Ayalasomayajula, S. P., Ashton, P., & Kompella, U. B. (2009) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2008.0090 · Cited by 44
Self-citationIodide iontophoresis as a treatment for dry eye syndrome
Horwath‐Winter, J. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.048314 · Cited by 40
A water-soluble prodrug of cyclosporine A for ocular application: A stability study
Lallemand, F., Perrottet, P., Felt-Baeyens, O., Kloeti, W., Philippoz, F., Marfurt, J., Besseghir, K., & Gurny, R. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.05.003 · Cited by 39
Transporters/receptors in the anterior chamber: pathways to explore ocular drug delivery strategies
Dey, S., Anand, B. S., Patel, J., & Mitra, A. K. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.1.23 · Cited by 35
Aukunuru, J., Sunkara, G., Ayalasomayajula, S. P., DeRuiter, J., Clark, R. C., & Kompella, U. B. (2002) · Pharmaceutical Research · doi:10.1023/a:1014438800893 · Cited by 32
Self-citationPrasanna, G., Fortner, J. H., Xiang, C. D., Zhang, E., Carreiro, S. T., Anderson, S., Sartnurak, S., Wu, G., Gukasyan, H. J., Niesman, M. R., et al. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.05.002 · Cited by 32
Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Bourges, J., Lallemand, F., Agla, E. K., et al. (2006) · PubMed · Cited by 31
Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes
Amrite, A. C., Pugazhenthi, V., Cheruvu, N. P. S., & Kompella, U. B. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003663236 · Cited by 30
Self-citationMembrane Transport Processes in the Eye
Sunkara, G., & Kompella, U. B. (2003) · CRC Press eBooks · doi:10.1201/9780203912072-6 · Cited by 30
Self-citationInfluence of Topically Applied Cyclosporine A in Olive Oil on Corneal Epithelium Permeability
del Castillo, J. M. B. T., del Aguila, C., Duran, S., et al. (1994) · Cornea · doi:10.1097/00003226-199403000-00006 · Cited by 28
Membrane Transport Processes in the Eye
Sunkara, G., & Kompella, U. B. (2003) · CRC Press eBooks · doi:10.1201/9780203912072.ch2 · Cited by 27
Self-citationMacha, S., Duvvuri, S., & Mitra, A. K. (2004) · Current Eye Research · doi:10.1076/ceyr.28.2.77.26233 · Cited by 24
Effect of Diabetes on Transscleral Delivery of Celecoxib
Cheruvu, N. P. S., Amrite, A. C., & Kompella, U. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9757-2 · Cited by 19
Self-citationLEE, Y., & Lee, V. H. L. (1993) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1993.9.47 · Cited by 17
Self-citation
Cited by
Deuterium‐ and Tritium‐Labelled Compounds: Applications in the Life Sciences
Atzrodt, J., Derdau, V., Kerr, W. J., & Reid, M. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201704146 · Cited by 810
Ocular drug delivery: present innovations and future challenges
Gote, V., Sikder, S., Sicotte, J., & Pal, D. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256933 · Cited by 441
Recent advances in ocular drug delivery
Achouri, D., Alhanout, K., Piccerelle, P., & Andrieu, V. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2012.736515 · Cited by 335
Xu, G.-T., Zhang, J.-F., & Tang, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.355743 · Cited by 280
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
Kompella, U. B., Amrite, A. C., Pacha Ravi, R., & Durazo, S. A. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.04.001 · Cited by 258
Self-citation
Metadata
- Authors
- Kompella, U. B., Kadam, R. S., & Lee, V. H.
- Venue
- Therapeutic Delivery
- Publisher
- Informa UK Limited
- Published
- 2010-09
- Volume
- 1
- Issue
- 3
- Pages
- 435-456
- ISSN
- 2041-5990 (ISSN-L)
- 2041-6008
- OpenAlex
- W2093470897
- Cited by
- 285
- References
- 92
- FWCI
- 10.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.